Literature DB >> 10661664

Incidence of trichiasis in a cohort of women with and without scarring.

B Muñoz1, L Bobo, H Mkocha, M Lynch, Y H Hsieh, S West.   

Abstract

BACKGROUND: Blindness from trachoma is a significant problem for many underdeveloped countries. While active trachoma is common in children, trichiasis, the potentially blinding sequella, develops in adulthood and affects mainly women. Little is known about factors associated with the development of trichiasis.
METHODS: The 7-year incidence of trichiasis and its association with ocular chlamydia infection was examined in a cohort of women from a hyperendemic area. A total of 4,932 women 18 years and older, living in 11 villages in Central Tanzania, were examined in 1989. A follow-up examination in 1996 was performed on all women with scars living in six of the 11 villages and on a random sample of women without scars from the same villages. Trachoma was graded clinically, chlamydia infection was ascertained at follow-up using polymerase chain reaction-enzyme immunoassay (PCR-EIA).
RESULTS: A total 523 of the women with scars and 503 of the women without scars were re-examined. Forty-eight of the women with scars (incidence, 9.2%) and three of the women without scars (0.6%) developed trichiasis in the 7-year period. Prevalence of chlamydia infection was significantly higher in the group with scars (11.7% versus 7.1%). Trichiasis cases were more likely to be older, and to have chlamydia infection at follow-up odds ratio (95% confidence interval) 2.5 (1.1-5.7).
CONCLUSION: The 7-year incidence rate in the population with scars was high, over 1% per year. Ocular chlamydia infection was more common in the group with scars at baseline and was also associated with being a trichiasis case, suggesting the importance of potentially long-term chlamydia infection in the progression to trichiasis. Antibiotic distribution programmes for trachoma control should include women with scars.

Entities:  

Mesh:

Year:  1999        PMID: 10661664     DOI: 10.1093/ije/28.6.1167

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  26 in total

1.  Can we eliminate trachoma?

Authors:  T Lietman; A Fry
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Bacterial infection in scarring trachoma.

Authors:  Victor H Hu; Patrick Massae; Helen A Weiss; Caroline Chevallier; Jecinta J Onyango; Isaac A Afwamba; David C W Mabey; Robin L Bailey; Matthew J Burton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

3.  Trachoma.

Authors:  J D Chidambaram; T M Lietman
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year.

Authors:  H Zhang; R P Kandel; H K Atakari; D Dean
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

5.  Fluorometholone 0.1% as Ancillary Therapy for Trachomatous Trichiasis Surgery: Randomized Clinical Trial.

Authors:  John H Kempen; Redda Tekle-Haimanot; Lelisa Hunduma; Menilik Alemayehu; Maxwell Pistilli; Aida Abashawl; Scott D Lawrence; Wondu Alemayehu
Journal:  Am J Ophthalmol       Date:  2018-09-27       Impact factor: 5.258

6.  Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.

Authors:  Jeremy D Keenan; Craig W See; Jeanne Moncada; Berhan Ayele; Teshome Gebre; Nicole E Stoller; Charles E McCulloch; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 7.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers.

Authors:  Muneer Abbas; Linda D Bobo; Yu-Hsiang Hsieh; Noureddine Berka; Georgia Dunston; George E Bonney; Victor Apprey; Thomas C Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

9.  Elimination of active trachoma after two topical mass treatments with azithromycin 1.5% eye drops.

Authors:  Abdou Amza; Pablo Goldschmidt; Ellen Einterz; Pierre Huguet; Celine Olmiere; Philippe Bensaid; Lucienne Bella-Assumpta
Journal:  PLoS Negl Trop Dis       Date:  2010-11-23

Review 10.  Application of molecular tools in the control of blinding trachoma.

Authors:  David Mabey; Anthony W Solomon
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.